State Street
CABA icon

State Street’s Cabaletta Bio CABA Stock Holding History

State Street’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$15.5M Buy
8,053,077
+213,772
+3% +$602K ﹤0.01% 2478
2026
Q2 		$24.4M Buy
7,839,305
+7,369,327
+1,568% +$24.2M ﹤0.01% 2273
2026
Q1 		$1.26M Buy
469,978
+44,500
+10% +$124K ﹤0.01% 3432
2025
Q4 		$932K Buy
425,478
+48,678
+13% +$121K ﹤0.01% 3538
2025
Q3 		$882K Buy
376,800
+158,833
+73% +$273K ﹤0.01% 3540
2025
Q2 		$331K Sell
217,967
-720,751
-77% -$1.12M ﹤0.01% 3708
2025
Q1 		$1.3M Buy
938,718
+740
+0.1% +$1.58K ﹤0.01% 3376
2024
Q4 		$2.13M Buy
937,978
+41,855
+5% +$147K ﹤0.01% 3299
2024
Q3 		$4.23M Sell
896,123
-1,109,678
-55% -$6.42M ﹤0.01% 3042
2024
Q2 		$15M Sell
2,005,801
-1,735,659
-46% -$21.3M ﹤0.01% 2314
2024
Q1 		$63.8M Buy
3,741,460
+1,146,990
+44% +$24.6M ﹤0.01% 1592
2023
Q4 		$58.9M Buy
2,594,470
+1,061,628
+69% +$17.8M ﹤0.01% 1620
2023
Q3 		$23.3M Buy
1,532,842
+1,071,345
+232% +$14.6M ﹤0.01% 2070
2023
Q2 		$5.96M Buy
461,497
+379,030
+460% +$4.11M ﹤0.01% 2912
2023
Q1 		$682K Sell
82,467
-5,200
-6% -$48.7K ﹤0.01% 3646
2022
Q4 		$811K Buy
87,667
+26,800
+44% +$97.6K ﹤0.01% 3612
2022
Q3 		$40K Hold
60,867
– – ﹤0.01% 4702
2022
Q2 		$65K Buy
60,867
+2,100
+4% +$2.97K ﹤0.01% 4665
2022
Q1 		$119K Buy
58,767
+2,760
+5% +$7.22K ﹤0.01% 4590
2021
Q4 		$212K Buy
56,007
+14,000
+33% +$149K ﹤0.01% 4323
2021
Q3 		$511K Buy
42,007
+19,200
+84% +$177K ﹤0.01% 3968
2021
Q2 		$196K Sell
22,807
-181,509
-89% -$1.78M ﹤0.01% 4217
2021
Q1 		$2.27M Buy
204,316
+4,685
+2% +$57.2K ﹤0.01% 3390
2020
Q4 		$2.49M Buy
199,631
+36,917
+23% +$479K ﹤0.01% 3274
2020
Q3 		$1.76M Buy
162,714
+29,222
+22% +$336K ﹤0.01% 3247
2020
Q2 		$1.49M Buy
133,492
+28,093
+27% +$215K ﹤0.01% 3296
2020
Q1 		$769K Buy
105,399
+60,085
+133% +$824K ﹤0.01% 3368
2019
Q4 		$633K Buy
+45,314
New +$537K ﹤0.01% 3487

Other funds holding CABA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
Propel Bio Management
Propel Bio Management Los Angeles, California $189M AUM 71.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

State Street's CABA Position: Q3 2026 in Review

State Street increased its Cabaletta Bio (CABA) stake by 2.7% in Q3 2026, buying an estimated $602K and bringing the position to 8,053,077 shares worth $15.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2478.

State Street first reported a position in CABA in Q4 2019 and has held it in 28 quarters since. The position peaked at $63.8M in Q1 2024. 86 funds tracked by Wall St. Rank hold CABA as of Q3 2026.

  • State Street held 8,053,077 shares of Cabaletta Bio worth $15.5M as of Q3 2026.
  • State Street bought 213,772 Cabaletta Bio shares in Q3 2026, an estimated $602K.
  • Cabaletta Bio made up ﹤0.01% of State Street's portfolio in Q3 2026, its #2478 holding.
  • State Street first reported a position in Cabaletta Bio in Q4 2019 and has held it in 28 quarters since.
  • State Street's Cabaletta Bio position peaked at $63.8M in Q1 2024.
  • 86 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2026.

Based on State Street's 13F filing for Q3 2026, filed 12 Nov 2026.